More MS news articles for September 2002

Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220551&dopt=Abstract

Cytokine Growth Factor Rev 2002 Aug;13(4-5):379
Taki S.
Department of Molecular Genetics, Chiba University Graduate School of Medicine, 1-8-1 Inohana, 260-8670, Chiba, Japan

Type I interferons (IFN-alpha/beta) are produced upon viral and bacterial infections and play essential roles in host defense.

However, since IFN-alpha/beta have multiple regulatory functions on innate and adoptive immunity, dysregulation of the IFN-alpha/beta system both in uninfected hosts and during immune responses against infection can result in immunopathologies.

In fact, IFN-alpha/beta therapy often accompanies autoimmune-like symptoms.

In this regard, we have recently found that mice lacking IFN regulatory factor (IRF)-2, a negative regulator of IFN-alpha/beta signaling, develop spontaneous, CD8(+) T cell-dependent skin inflammation.

This unique animal model, together with other animal models, highlights the importance of the mechanism maintaining the homeostasis in the IFN-alpha/beta system even in the absence of infection.